Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

Experimental & Molecular Medicine
Bhumsoo Kim, Eva L Feldman

Abstract

Metabolic syndrome (MetS) is a cluster of cardiovascular risk factors that includes obesity, diabetes, and dyslipidemia. Accumulating evidence implies that MetS contributes to the development and progression of Alzheimer's disease (AD); however, the factors connecting this association have not been determined. Insulin resistance (IR) is at the core of MetS and likely represent the key link between MetS and AD. In the central nervous system, insulin plays key roles in learning and memory, and AD patients exhibit impaired insulin signaling that is similar to that observed in MetS. As we face an alarming increase in obesity and T2D in all age groups, understanding the relationship between MetS and AD is vital for the identification of potential therapeutic targets. Recently, several diabetes therapies that enhance insulin signaling are being tested for a potential therapeutic benefit in AD and dementia. In this review, we will discuss MetS as a risk factor for AD, focusing on IR and the recent progress and future directions of insulin-based therapies.

Associated Clinical Trials

References

Jul 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·I Grundke-IqbalL I Binder
Jan 1, 1987·Annual Review of Physiology·D G BaskinD M Dorsa
Apr 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·K M MacLeodB M Frier
Feb 15, 1997·American Journal of Epidemiology·C L LeibsonP J Palumbo
Dec 22, 1999·Neurology·A OttM M Breteler
Feb 17, 2000·The Journal of Clinical Investigation·K CusiL J Mandarino
Nov 23, 2000·Biochemistry·T C GamblinL I Binder
Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·E KojroF Fahrenholz
Oct 13, 2001·Neuroendocrinology·W KernH L Fehm
Oct 27, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·R CoswayI J Deary
Aug 20, 2003·Nature Medicine·Matthew J DuringColin N Haile
Sep 30, 2003·Diabetes Care·Daniel J Drucker
Jan 30, 2004·Diabetes·Juliette JansonPeter C Butler
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Markus SchubertJens C Brüning
Mar 19, 2004·Diabetes & Metabolism·B Vergès
Mar 20, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Reijo S TilvisTimo E Strandberg
Jun 11, 2004·Journal of Neurochemistry·Ratan V BhatJesús Avila
Oct 13, 2005·Neurobiology of Aging·Gordon Winocur, Carol E Greenwood
Dec 20, 2005·Lancet Neurology·Geert Jan BiesselsPhilip Scheltens
Feb 1, 2006·The Pharmacogenomics Journal·M E RisnerUNKNOWN Rosiglitazone in Alzheimer's Disease Study Group
Mar 7, 2006·Experimental Neurology·Ward A PedersenGleb R Haynatzki
Apr 22, 2006·Journal of Alzheimer's Disease : JAD·Nataniel Lester-CollSuzanne M de la Monte
Aug 18, 2006·Journal of Alzheimer's Disease : JAD·Akihiko Takashima
Aug 19, 2006·Progress in Neurobiology·Lars P van der HeideMarten P Smidt
Aug 29, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Christian BenedictWerner Kern
Sep 22, 2006·Journal of Alzheimer's Disease : JAD·Suzanne M de la MonteJack R Wands
Dec 13, 2006·Best Practice & Research. Clinical Endocrinology & Metabolism·Giorgio Sesti
Mar 14, 2007·Archives of Neurology·José A LuchsingerRichard Mayeux
Apr 4, 2007·Cell Metabolism·Shaohui Huang, Michael P Czech
Apr 14, 2007·Current Alzheimer Research·Rachel A WhitmerKristine Yaffe
Sep 15, 2007·The Journal of Biological Chemistry·Matthew TownsendDennis J Selkoe
Oct 9, 2007·Brain Research Reviews·Lin Li, Christian Hölscher
Oct 18, 2007·Molecular BioSystems·Wagner B Dias, Gerald W Hart

❮ Previous
Next ❯

Citations

Feb 18, 2016·Neural Plasticity·Chuanming WangJin H Yan
Nov 8, 2015·Biochimica Et Biophysica Acta·Makoto Ishii, Costantino Iadecola
Mar 20, 2016·Cellular and Molecular Neurobiology·Matthew J McGuire, Makoto Ishii
Apr 15, 2016·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Roshan GunathilakeJohn Attia
May 29, 2016·Physiology & Behavior·Vanita RaniJitender Bariwal
Jul 6, 2016·Aging Clinical and Experimental Research·Paulo de O DuarteNereida K C Lima
Jun 7, 2017·Journal of Alzheimer's Disease : JAD·Warnakulasuriya M A D B FernandoRalph N Martins
Feb 22, 2018·Genes·Alessandra Castegna, Alessio Menga
May 24, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Blessing A Aderibigbe, Tobeka Naki
Sep 14, 2017·Journal of the American Heart Association·Yen-Chun FanChyi-Huey Bai
Aug 3, 2018·The European Journal of Neuroscience·Dilan AthaudaThomas Foltynie
Feb 17, 2019·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Christopher J Nolan, Marc Prentki
Nov 27, 2018·The Journal of Endocrinology·Lenka MaletínskáJaroslav Kuneš
Sep 12, 2017·The Proceedings of the Nutrition Society·Louise DyeClare Lawton
Mar 5, 2019·Current Alzheimer Research·Firas H BazzariHanan S El-Abhar
May 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Firas H BazzariHanan S El-Abhar
Nov 18, 2015·Current Opinion in Psychiatry·Tomas HajekMartin Alda
Mar 15, 2020·Brain and Behavior·Jalaja MadhusudhananVasudharani Devanathan
Jul 1, 2020·Fundamental & Clinical Pharmacology·Adel A GomaaMariam A Nicola
Jul 28, 2016·Metabolic Brain Disease·Yun Fei WangLong Jiang Zhang
May 8, 2018·Frontiers in Neuroscience·Melisa EtchegoyenMatilde Otero-Losada
Aug 29, 2018·Journal of Alzheimer's Disease : JAD·Jared M CampbellEdoardo Aromataris

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Clinical Trials Mentioned

NCT01255163
NCT01843075

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

Current Neurology and Neuroscience Reports
Jill K Morris, Jeffrey M Burns
Journal of the American Geriatrics Society
Paola FortiGiovanni Ravaglia
Trends in Endocrinology and Metabolism : TEM
Bhumsoo Kim, Eva L Feldman
Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Sergio T FerreiraFernanda G De Felice
© 2021 Meta ULC. All rights reserved